| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |